2-(3-溴苯胺基)乙酸乙酯 | 2521-91-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-(3-溴苯胺基)乙酸乙酯
• 中文别名: 2-((3-溴苯基)氨基)乙酸乙酯
• 英文名称: ethyl (3-bromophenyl)glycinate
• 英文别名: ethyl N-(3-bromophenyl)glycinate；Ethyl 2-((3-bromophenyl)amino)acetate；ethyl 2-(3-bromoanilino)acetate
• CAS: 2521-91-7
• 化学式: C₁₀H₁₂BrNO₂
• mdl: MFCD00461413
• 分子量: 258.115
• InChiKey: JASOGFHEWZGRCJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302

反应信息

• 作为反应物：
  描述：

  2-(3-溴苯胺基)乙酸乙酯 在 palladium on activated charcoal 盐酸 、 bis(triphenylphosphine)palladium(II)-chloride 、 氢气 、 三乙胺 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 100.0 ℃ 、344.73 kPa 条件下， 反应 25.0h， 生成 N-<3-(3-phosphonopropyl)phenyl>glycine
  参考文献：
  名称：

  Exploration of N-phosphonoalkyl-, N-phosphonoalkenyl-, and N-(phosphonoalkyl)phenyl-spaced .alpha.-amino acids as competitive N-methyl-D-aspartic acid antagonists

  摘要：

  A series of N-substituted alpha-amino acids containing terminal phosphonic acid groups has been synthesized as potential N-methyl-D-aspartate (NMDA) receptor antagonists. NMDA receptor affinity was determined by displacement of a known ligand ([H-3]CPP) from crude rat brain synaptic membranes; an antagonist action was demonstrated by the inhibition of glutamate-induced accumulation of [Ca-45(2+)] in cultured rat cortical neurons. Receptor affinity was significantly correlated with antagonist activity (Figure 1). Moderate affinity (IC50 = 1-2-mu-M) was retained for analogues (31 and 32, Table 1; and 59 and 66, Table II) with reduced flexibility in their phosphonate side chains and is consistent with entropy playing a role in determining receptor affinity. Modeling studies suggest a folded conformation that brings the distal phosphonic acid group into close proximity with the alpha-carboxylate is required for binding. Each of the active analogues possess entropy-limiting features (double bonds, phenyl rings) in their side chains that allows the superposition of their key NH2, alpha-COOH, and distal PO3H2 groups with those of known competitive antagonists. Affinity decreased for analogues with alpha-carbon substitution, presumably because the alpha-substituent inhibits the folding of these structures into a bioactive conformation and occupies receptor-excluded volume. A complete description of the NMDA antagonist pharmacophore model is provided in a companion paper. 1

  DOI：

  10.1021/jm00086a005
• 作为产物：
  描述：

  溴乙酸乙酯 、 间溴苯胺 在 potassium carbonate 作用下， 生成 2-(3-溴苯胺基)乙酸乙酯
  参考文献：
  名称：

  含芳基异羟肟酸的尿素酶抑制剂，可有效治疗幽门螺杆菌感染

  摘要：

  设计，合成和评估了一系列新型的含苯胺的异羟肟酸，作为抗毒剂，用于治疗幽门螺杆菌引起的胃炎和胃溃疡。基于体外酶的筛选以及体内测定和结构活性关系（SAR）研究导致发现了三种有效的脲酶抑制剂3-（3,5-二氯苯基氨基）N-羟基丙酰胺（3a），3-（2-氯苯基氨基）N-羟基丙酰胺（3d）和3-（2,4-二氯苯基氨基）N-羟基丙酰胺（3n）。化合物3a，3d和3n表现出优异的脲酶抑制作用，IC 50值为0.043±0.005、0.055±0.008和0.018±0.002μM，并且在32 mg / kg bid剂量下显着抑制了胃炎的发展，根除幽门螺杆菌的比率达到92.3、84.6和100％，分别。初步安全性研究（对小鼠的急性毒性）显示，LD 50分别为2982.8、3349.4和3126.9 mg / kg的KM小鼠对3a，3d和3n的耐受性良好。总体而言，本研究中获得的数据表明3a，3d和3n，尤

  DOI：

  10.1016/j.ejmech.2018.06.065

文献信息

• 一种3,4-二氢喹唑啉衍生物及其制备方法、应用
  申请人：郑州大学

  公开号：CN110003121A

  公开（公告）日：2019-07-12

  本发明属于有机合成技术领域，具体涉及一种3,4‑二氢喹唑啉衍生物及其制备方法、应用。本发明的3,4‑二氢喹唑啉衍生物，其结构式为其中，R1～R4分别选自氢、卤素、烷基、取代烷基、烷氧基、苄基中的一种；R5～R7分别选自氢、卤素、烷氧基、取代烷基中的一种；R8选自羟基、酰胺基、亚磷酸酯基中的一种。本发明提供了一种多取代的3,4‑二氢喹唑啉衍生物，该3,4‑二氢喹唑啉衍生物具有芳香基，是一种用途广泛的有机合成中间体，在医药生产及有机合成领域具有重要的应用价值，可用作T型钙通道阻滞剂、锥虫硫酮还原酶(TryR)抑制剂和抗癌试剂，并表现出抗肿瘤生物活性。
• N-substituted .alpha.-amino acids and derivatives thereof having
  申请人：Warner-Lambert Company

  公开号：US05179085A1

  公开（公告）日：1993-01-12

  N-substituted .alpha.-amino acids and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful in selectively blocking the N-methyl-D-aspartate (NMDA) excitatory amino acid receptors in mammals and also are useful in treating cerebrovascular disorders such as cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasm, hypoglycemia, cardiac arrest, status epilepticus and cerebral trauma as well as for treating schizophrenia, epilepsy, neurodegenerative disorders, Alzheimer's disease or Huntington's disease and also additionally useful as anesthetics in surgical procedures where a finite risk of cerebrovascular damage exists.

  N-取代的α-氨基酸及其衍生物被描述，以及用于制备和药物组合物的方法，这些方法在选择性阻断哺乳动物的N-甲基-D-天门冬氨酸(NMDA)兴奋性氨基酸受体方面是有用的，在治疗脑血管疾病如脑梗塞或脑梗塞、脑动脉痉挛、低血糖、心脏骤停、癫痫状态和脑外伤以及治疗精神分裂症、癫痫、神经退行性疾病、阿尔茨海默病或亨廷顿病方面也有用，并可作为外科手术中的麻醉剂，其中存在有限的脑血管损伤风险。
• Copper-Catalyzed Oxidative [4 + 2]-Cyclization Reaction of Glycine Esters with Anthranils: Access to 3,4-Dihydroquinazolines
  作者：Jie Ren、Chao Pi、Yangjie Wu、Xiuling Cui

  DOI：10.1021/acs.orglett.9b01246

  日期：2019.6.7

  synthesis of 3,4-dihydroquinazolines has been developed via copper-catalyzed oxidative cross-dehydrogenative [4 + 2]-cyclization of glycine derivatives with anthranils. This strategy features high efficiency and wide substrate tolerance under simple reaction conditions. Various 3,4-dihydroquinazoline derivatives could be easily obtained starting from titled products through chemical transformations, which

  通过铜催化甘氨酸衍生物与蒽基的氧化交叉脱氢[4 + 2]环化反应，已开发出一种高效且原子经济的合成3,4-二氢喹唑啉的方法。该策略的特点是在简单的反应条件下具有高效率和宽底物耐受性。可以从标题产物开始通过化学转化容易地获得各种3,4-二氢喹唑啉衍生物，这进一步增强了其在有机合成和药物开发中的合成效用。
• Enantioselective synthesis of arylglycine derivatives by direct C–H oxidative cross-coupling
  作者：Xiao-Hong Wei、Gang-Wei Wang、Shang-Dong Yang

  DOI：10.1039/c4cc07361d

  日期：——

  A new method for the synthesis of chiral alpha-amino acid derivatives by enantioselective C-H arylation of N-aryl glycine esters with aryl boric acids in the presence of a chiral Pd(II)-catalyst has been developed. This work successfully integrates the direct C-H oxidation with asymmetric arylation and exhibits excellent enantioselectivity.

  已开发出一种在手性Pd（II）催化剂存在下通过N-芳基甘氨酸酯与芳基硼酸的对映选择性CH芳基化合成手性α-氨基酸衍生物的新方法。这项工作成功地将直接CH氧化与不对称芳基化相结合，并表现出出色的对映选择性。
• Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection
  作者：Qi Liu、Wei-Kang Shi、Shen-Zhen Ren、Wei-Wei Ni、Wei-Yi Li、Hui-Min Chen、Pei Liu、Jing Yuan、Xiao-Su He、Jia-Jia Liu、Peng Cao、Pu-Zhen Yang、Zhu-Ping Xiao、Hai-Liang Zhu

  DOI：10.1016/j.ejmech.2018.06.065

  日期：2018.8

  evaluated as anti-virulence agents for the treatment of gastritis and gastric ulcer caused by Helicobacter pylori. In vitro enzyme-based screen together with in vivo assays and structure−activity relationship (SAR) studies led to the discovery of three potent urease inhibitors 3-(3,5-dichlorophenylamino)N-hydroxypropanamide (3a), 3-(2-chlorophenylamino)N-hydroxypropanamide (3d) and 3-(2,4-dichlorophenylam

  设计，合成和评估了一系列新型的含苯胺的异羟肟酸，作为抗毒剂，用于治疗幽门螺杆菌引起的胃炎和胃溃疡。基于体外酶的筛选以及体内测定和结构活性关系（SAR）研究导致发现了三种有效的脲酶抑制剂3-（3,5-二氯苯基氨基）N-羟基丙酰胺（3a），3-（2-氯苯基氨基）N-羟基丙酰胺（3d）和3-（2,4-二氯苯基氨基）N-羟基丙酰胺（3n）。化合物3a，3d和3n表现出优异的脲酶抑制作用，IC 50值为0.043±0.005、0.055±0.008和0.018±0.002μM，并且在32 mg / kg bid剂量下显着抑制了胃炎的发展，根除幽门螺杆菌的比率达到92.3、84.6和100％，分别。初步安全性研究（对小鼠的急性毒性）显示，LD 50分别为2982.8、3349.4和3126.9 mg / kg的KM小鼠对3a，3d和3n的耐受性良好。总体而言，本研究中获得的数据表明3a，3d和3n，尤